Clinical and Instrumental Assessment of Meniscal ROOT Tears Treated Through Suture to the Posterior Cruciate Ligament
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Jul 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical method to treat meniscal root tears, which are injuries to a crucial part of the knee that helps keep it stable. These tears can lead to joint pain and potentially cause arthritis over time. The trial is looking at how well a specific technique—using arthroscopic sutures to connect the meniscal root to the posterior cruciate ligament—works in fixing these tears, especially since early diagnosis can be challenging. This method does not require detailed planning beforehand, making it suitable for patients who may be diagnosed with these tears during other treatments.
To be eligible for the study, participants must be between 18 and 50 years old and need to be scheduled for surgery to repair a root meniscal tear using this new technique. They should have had an MRI before the surgery. However, individuals with certain conditions, such as serious knee arthritis or severe obesity, may not qualify. Participants in the trial can expect to undergo surgery and then be monitored to see how well the procedure helps improve their knee function and reduce pain. This research aims to improve treatment options for knee injuries and enhance recovery outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age between 18 and 50 years at the time of surgery;
- • 2. Male and female gender;
- • 3. Patients undergoing surgical treatment for at least one year for "ROOT" type meniscal lesions using arthroscopic suturing to the posterior cruciate ligament;
- • 4. Pre-operative MRI performed.
- Exclusion Criteria:
- • 1. Patients no longer reachable;
- • 2. Patients who refuse consent to the study;
- • 3. Previous meniscectomy before surgery;
- • 4. Previous ligament injuries before surgery;
- • 5. New traumatic injuries after surgery;
- • 6. Advanced knee osteoarthritis (Outerbridge grade III-IV) at the time of surgery;
- • 7. Severe knee malalignment (\> 5°) at the time of surgery;
- • 8. Severe obesity (BMI \> 35);
- • 9. Lower limb conditions preventing full weight-bearing during evaluation;
- • 10. Infection or hematological/rheumatic conditions at the time of evaluation.
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported